BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 17/09/2025

FDA Announces Draft Guidance for Symptomatic Nonerosive Gastroesophageal Reflux Disease Treatment

The FDA has released a draft guidance outlining its recommendations for developing drugs to treat symptomatic nonerosive gastroesophageal reflux disease in adults, including clinical trial design and efficacy evaluations.

Source: Federal Register — Food and Drug AdministrationOpen original release →